Jeena Sikho Lifecare Limited expanded its healthcare and wellness portfolio by launching Amrit Dhara Drops 20 ml on August 4, 2026. The new Ayurvedic product is designed for the domestic market and focuses on managing cold and cough symptoms using traditionally used herbs. This launch reinforces the company’s presence in the herbal remedies segment, adding to its existing network of over 120 Ayurveda clinics and hospitals.

The company disclosed the launch under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The information was submitted to both the National Stock Exchange of India Limited and BSE Limited.

Product Details

The key specifications of the newly launched product are outlined below:

Manish Grover, Managing Director of Jeena Sikho Lifecare Limited, signed the intimation filed with the stock exchanges. The company operates from its registered office in Zirakpur, Punjab, and its corporate office in New Multan Nagar, Delhi.

Strategic Context

The introduction of Amrit Dhara Drops aligns with Jeena Sikho Lifecare’s broader strategy to offer drug-free solutions for common ailments. By targeting the domestic market with a specialized formulation for cold and cough, the company aims to deepen its penetration in the consumer-facing Ayurvedic sector. The product packaging highlights traditional herbs, emphasizing the natural composition of the drops.

This expansion adds a new SKU to the company’s offerings without entering international markets at this stage. The focus remains on leveraging the company’s extensive clinic network to drive awareness and sales within India.

Jeena Sikho Lifecare Jeena Sikho Lifecare expanded its healthcare portfolio on July 27, 2026, by launching four new Ayurvedic pain relief products. The launch strengthens the company’s range of external application solutions, adding specialized patches for back and knee pain alongside general-purpose variants. This move broadens the company’s domestic market offerings within the scientific Ayurveda segment.

The company disclosed the product launches under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was submitted to both the National Stock Exchange of India Limited and BSE Limited. The disclosure aligns with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Product Portfolio Expansion

The newly launched products cater exclusively to the domestic market. Each variant is designed for specific body areas or general use, featuring natural herbal formulas as highlighted in their packaging. The products are recommended by Acharya Manish Ji, as indicated on the packaging materials.

Regulatory Compliance

Manish Grover, Managing Director of Jeena Sikho Lifecare Limited (DIN: 07557886), signed the disclosure from the company’s registered office in Zirakpur, Punjab. The detailed particulars for each product were provided in Annexures A to D attached to the exchange filings. The company confirmed that this information is also available on its official website, www.jeenasikho.com .

The expansion adds to the company’s existing presence across 120+ Ayurveda clinics and hospitals. The new SKUs allow the company to address specific pain points such as back flexibility and joint mobility with targeted formulations.